Where the Money Goes

You are here

ALSF Childhood Cancer Research Grants

With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,000 funded projects below.

Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.

You can learn about ALSF's grant review process here.

ALSF Funded Research Projects

Project Title	Institution / Principal Investigator(s)	Grant Type	Year	State
Identify Novel Druggable Targets to Treat Philadelphia chromosome-like B-Acute Lymphoblastic Leukemia	Children's Hospital of Philadelphia / Wei Tong, PhD	Innovation Grants	2019	Pennsylvania
Using Splice Switching Oligonucleotides (SSOs) to target MDM2 for rhabdomyosarcoma therapy	Research Institute at Nationwide Children's Hospital / Dawn Chandler, PhD	Innovation Grants	2019	Ohio
Targeting mechanisms of Siglec15-mediated immune evasion in hematologic malignancies	Emory University / Christopher Porter, MD	Innovation Grants	2019	Georgia
The anti-tumor immune microenvironment in the Sonic Hedgehog subclass of medulloblastoma	Emory University / Anna Kenney, PhD	Innovation Grants	2019	Georgia
Therapeutic Targeting of the Disrupted Metabolic State in DIPG	University of Michigan / Costas Lyssiotis, PhD & Sriram Venneti, MD/PhD	Innovation Grants	2019	Michigan
Norepinephrine Transporter-Targeted Pharmacotherapy of Aggressive Neuroblastoma	Children's Hospital of Philadelphia / Michael Chorny, PhD	Innovation Grants	2019	Pennsylvania
Targeting microenvironment-induced TGFB signaling to overcome drug resistance in acute lymphoblastic leukemia	St. Jude Children's Research Hospital / Charles Mullighan, MD	Innovation Grants	2019	Tennessee
Novel Therapy of Heterogeneous B-cell Acute Lymphocytic Leukemia by Targeting Convergent Oncogenic Mediators STATs	University of Alberta / Hasan Uludag, PhD	Innovation Grants	2019	Alberta
Selectively targeting EP300 with small molecules for neuroblastoma (NB) therapy	Dana-Farber Cancer Institute / Jun Qi, PhD	Innovation Grants	2019	Massachusetts
Developing drugs to treat NT5C2 mediated resistance in pediatric ALL	New York University School of Medicine / William Carroll, MD	Innovation Grants	2019	New York

Pages